from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2543/lppA

LFCtreatmentdescriptionclass of inhibitor

1.279

Amikacinug/mL Amikacintranslation

1.099

Cap5-10ug/mL Capreomycintranslation

1.658

Rox10-50 ug/mL Roxithromycintranslation

0.139

SM2-5 ug/mL Streptomycintranslation

2.059

Tet5-10 ug/mL Tetracyclinetranslation

-1.194

Rif0.2-5ug/mL Rifampicintranscription

-0.010

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.120

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.289

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.183

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.131

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.077

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.385

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.169

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.218

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.022

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.873

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.771

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.323

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.433

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.210

KCN5-20 ug/mL Potassium cyaniderespiration

0.374

NaN30.2-2 mM Sodium aziderespiration

-1.425

Nigericin50 uM Nigericinrespiration

-0.445

TRC10-150 ug/mL Triclosanrespiration

0.413

TRZ10-25 ug/mL Thioridazinerespiration

1.303

Valinomycin0.5-10 uM Valinomycinrespiration

0.271

ZnSO42 mM ZnSO4respiration

-0.002

menadione6-10 ug/mL Menadionerespiration

-0.188

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.395

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.375

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.179

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.724

NRP_1Non-replicating persistence stage 1dosRassociated

0.137

Amp0.2mg/mL AmpicillincellWall

0.359

Cephalexin20-100 ug/mL CephalexincellWall

0.137

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.988

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.688

EMB10-20 ug/mL EthambutolcellWall

0.572

Eta12-40 ug/mL EthionamidecellWall

0.549

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.567

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.631

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.279

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.648

BZA0.12 mg/mL BenzamidearomaticAmides

0.368

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.519

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.107

H2O24 mM hydrogen peroxideDNAdamaging

0.136

Levo10 ug/mL LevofloxacinDNAdamaging

-1.287

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.444

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.083

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.916

UVUV-irradiationDNAdamaging

0.328

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.157

Antimycin12.5-50 ug/mL Antimycin A?

0.137

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.197

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.429

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.409

PA8240.2-2 ug/mL PA-824?

1.463

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.532

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.398

Verapamil50 uM Verapamil?

-0.398

mercaptoethanol2 mM 2-Mercaptoethanol?

0.297

methoxatin10-20 ug/mL Methoxatin?